- 1 February 2021
IF YOU PRESCRIBE SUBSCRIBE
If you’re a health professional, subscribe to receive regular email updates from Australian Prescriber
-
Volume 44 Issue 1
February 2021 - February 2021
Article
Stephen Macfarlane, Colm
Cunningham
Article
COVID‑19 vaccines – are we there yet?
Peter McIntyre, Ye Jin Joo,
Clayton Chiu, Katie Flanagan, Kristine
Macartney
- 1 February 2021
-
Article
Is it time to stop using statistical significance?
Oliver Frank, CW Michael Tam,
Joel Rhee
- 1 February 2021
-
Editorial
Reporting adverse drug events to the Therapeutic Goods Administration
Jennifer H Martin, Catherine
Lucas
- 1 February 2021
Editorial
Policing the promotion of prescription medicines – the new Medicines Australia Code of Conduct
Barbara Mintzes
- 1 February 2021
Letters to the
Editor
Evolving evidence for immunosuppressants in COVID-19
Ajay K Shukla, Senthuran
Shivakumar, Olivia C Smibert, Jason A
Trubiano, Albert G Frauman, David FL
Liew
- 1 February 2021
Letters to the
Editor
More prescribing resources for medicinal cannabis
Sharna Glover, Sarah Dinh,
Sasha Bennett
- 1 February 2021
NEW DRUGS
Caplacizumab for thrombotic thrombocytopenic purpura
- 1 February 2021
Midodrine for orthostatic hypotension
- 1 February 2021
IF YOU PRESCRIBE SUBSCRIBE
If you’re a health professional, subscribe to receive regular email updates from Australian Prescriber
